¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10
±³À°ÀÏÀÚ : 2023-06-10
±³À°Àå¼Ò : µ¿°ü 6Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-3010-3130  

À̸ÞÀÏ : plm3010@amc.seoul.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í 1.Àü¹®ÀÇ »çÀüÁ¢¼ö 50,000¿ø ÇöÀåÁ¢¼ö 60,000¿ø2. ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç, ±âŸ µî »çÀüÁ¢¼ö 40,000¿ø ÇöÀåÁ¢¼ö 50,000¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:00~09:25 Refractory chronic cough: Mechanisms and treatment updates ¼Û¿ìÁ¤(¼­¿ï¾Æ»êº´¿ø ¾Ë·¹¸£±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:25~09:50 The optimal treatment of MAC pulmonary disease Á¶°æ¿í(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:50~10:15 Beyond inhaler: non-pharmacologic treatment in COPD À̼¼¿ø(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

ÈÞ½Ä 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:15~10:30 COFFEE BREAK ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:30~10:40 Importance of accurate nodal staging in stage III NSCLC Áö¿øÁØ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:40~11:05 Optimal strategy of surgical treatment in stage III NSCLC À±À籤(¼­¿ï¾Æ»êº´¿ø ½ÉÀåÇ÷°üÈäºÎ¿Ü°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:05~11:30 Update of perioperative chemotherapy in stage III NSCLC À±½Å±³(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:30~11:55 Current practice of radiation therapy in stage III NSCLC ½Å¿µ¼·(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

½Ä»ç 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:55~13:00 LUNCH ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:00~13:25 Updated IPF guideline and PPF (progressive pulmonary fibrosis : radiologic aspect äÀºÁø(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:25~13:50 Hopes and concerns about PAH targeted therapy in PH-ILD ÀÌÀç½Â(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:50~14:15 Lung transplantation in ILD patients ±èȣö(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

ÈÞ½Ä 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:15~14:30 COFFEE BREAK ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:30~14:55 Effect of corticosteroid therapy in severe pneumonia and ARDS ÇãÁø¿ø(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:55~15:20 Severe viral pneumonia other than COVID-19 ÃÖ»óÈ£(¼­¿ï¾Æ»êº´¿ø °¨¿°³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 15:20~15:45 Treatment of moderate to severe ARDS ¾ÈÁöȯ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2023-06-10
´ÙÀ½±Û 2023³â ¼­¿ï¾Æ»êº´¿ø ³úÁ¹Áß ½ÉÆ÷Áö¾ö From Basic Principles to Advanced Techniques : 2023-06-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
153 ºÎ»ê ´ëÇѾȰúÇÐȸ ÇмúÁý´ãȸ(³ì³»Àå, New trends of glaucoma treatment) : 2018-08-30 0 917 2018-07-28
152 °æ±â Çϳ²½Ã ÀÇ»çȸ ¿¬¼ö°­ÁÂ(Ç÷°ü¼ºÄ¡¸Å, °¨¿°³»°ú °¨¿°Áúȯ) : 2018-08-30 0 2,098 2018-07-28
151 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø °¢¸· Áúȯ : 2018-08-29 0 762 2018-07-28
150 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø Ȳ¹ÝºÎÁ¾ ¹× Ȳ¹Ýº¯¼º : 2018-08-28 0 692 2018-07-28
149 ´ë±¸ ´ëÇѾȰúÇÐȸ 2018³â ´ë±¸ °æºÏ ¾È°ú Áöȸ Á¤±â ¿¬¼ö±³À° : 2018-08-28 0 720 2018-07-28
148 ºÎ»ê ½Å°æ¿µ»óÀÇÇÐÀÇ ÇмúÁõ·Ê¹ßÇ¥ : 2018-08-28 0 317 2018-07-28
147 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ Á¤±âÁý´ãȸ : 2018-08-27 0 567 2018-07-28
146 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇа­Á : 2018-08-26 0 613 2018-07-28
145 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Cadaver Workshop : 2018-08-26 0 670 2018-07-28
144 ¼­¿ï °³¿ø 50Áֳ⠱â³ä Á¦ 9ȸ °­ºÏ»ï¼ºº´¿ø ´ç´¢Ç÷°ü¼¾ÅÍ ¿¬¼ö°­Á -´ç´¢º´ °ü¸® ¹× ÇÕº´Áõ ¿¹¹æÀ» À§ÇÑ 100³â ´ë°è : 2018-08-26 0 965 2018-07-28
143 ´ëÀü ´ëÇÑ°»³â±âÇÐȸ 2018 ÇÏ°è¿öÅ©¼¥ : 2018-08-26 0 653 2018-07-28
142 ¼­¿ï 2018³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦21Â÷ °ñ´Ù°øÁõ ¿¬¼ö°­Á : 2018-08-26 0 360 2018-07-28
141 ¼­¿ï Á¦16Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2018-08-26 0 506 2018-07-28
140 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease (Day 2) : 2018-08-26 0 371 2018-07-28
139 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ ¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø À̺ñÀÎÈÄ°ú 50Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2018-08-26 0 503 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷